Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancer.
about
Dose escalation with overdose control using a quasi-continuous toxicity score in cancer Phase I clinical trials.Neo-adjuvant chemo-radiation of rectal cancer with volumetric modulated arc therapy: summary of technical and dosimetric features and early clinical experience.Adaptive dose-finding studies: a review of model-guided phase I clinical trials.Long-term results from a randomized phase II trial of neoadjuvant combined-modality therapy for locally advanced rectal cancerNRG Oncology Radiation Therapy Oncology Group 0822: A Phase 2 Study of Preoperative Chemoradiation Therapy Using Intensity Modulated Radiation Therapy in Combination With Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer.Comparison of conventional and three-dimensional conformal CT planning techniques for preoperative chemoradiotherapy for locally advanced rectal cancer.Future directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapyElective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas.Planning and delivery of intensity-modulated radiation therapy.Radiation therapy for rectal cancer: current status and future directions.Preoperative chemoradiotherapy for rectal cancer: a comparison between intravenous 5-fluorouracil and oral capecitabine.Complete pathological responses in locally advanced rectal cancer after preoperative IMRT and integrated-boost chemoradiation.Adaptive radiation dose escalation in rectal adenocarcinoma: a review.A phase II trial of preoperative concurrent chemotherapy and dose escalated intensity modulated radiotherapy (IMRT) for locally advanced rectal cancer.The Impact of Novel Radiation Treatment Techniques on Toxicity and Clinical Outcomes In Rectal Cancer.Prospective study of neoadjuvant chemoradiotherapy using intensity-modulated radiotherapy and 5 fluorouracil for locally advanced rectal cancer - toxicities and response assessment.Escalation with Overdose Control Using Ordinal Toxicity Grades for Cancer Phase I Clinical TrialsNumber of Patients per Cohort and Sample Size Considerations Using Dose Escalation with Overdose Control
P2860
Q33714319-512D71EF-F1FE-4256-BD0A-98958D484261Q33729118-583007D8-2DD0-400C-B9D7-E896E22C69B6Q34001009-8F0ACE81-CB0D-416C-9CCE-9624503F9D48Q34202729-19551EB0-FC08-439F-9C6E-38D96F7FFEA5Q35967483-01381781-2A1C-4385-AF35-8B4FABB36F92Q36325238-BCE62470-D883-4940-9EF4-A57E98B28D4CQ37106318-AB1D6B1B-2860-4F2A-8DEE-756A2E967841Q37258339-683B45F8-1923-4F4F-B126-24EFC3B0D9BCQ37379087-E7F388A7-2ECA-4F34-85B0-A1990400B742Q37654670-14940960-2A32-4BB0-A01D-D3F7F6FA88ACQ42974975-FC1D4372-2973-4FD7-BF66-11D021713590Q44717104-1314ED66-9479-4169-8068-71DC5BF3D39EQ45340414-603A172D-4800-45B9-A175-1194B0079D12Q47126907-90B83CE2-D9EC-4796-A86E-57F238EF4753Q49531454-21941C22-0AB4-4370-A77A-912E192725BEQ55359250-839080FE-E2B6-40B7-9F39-5B1FDFD52D12Q58910958-E43F2D2C-86A4-400C-AED4-25D519BC8F45Q58910979-D13B4DEE-00D7-4F88-881B-7D36CD52538C
P2860
Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Phase I trial of preoperative ...... ocally advanced rectal cancer.
@en
Phase I trial of preoperative ...... ocally advanced rectal cancer.
@nl
type
label
Phase I trial of preoperative ...... ocally advanced rectal cancer.
@en
Phase I trial of preoperative ...... ocally advanced rectal cancer.
@nl
prefLabel
Phase I trial of preoperative ...... ocally advanced rectal cancer.
@en
Phase I trial of preoperative ...... ocally advanced rectal cancer.
@nl
P2093
P1476
Phase I trial of preoperative ...... ocally advanced rectal cancer.
@en
P2093
Andre Konski
André Rogatko
Elaine Callahan
Elin R Sigurdson
Gary M Freedman
John Hoffman
Jonathan Cheng
Nancy Lewis
Neal J Meropol
Robert Price
P304
P356
10.1016/J.IJROBP.2006.11.017
P407
P577
2007-04-01T00:00:00Z